Allenvik

ZOM looking for some gains.

AMEX:ZOM   Zomedica Corp.
With a clear breakout, and with its new TRUFORMA product, almost ready for commercialization, ZOM is finally showing some strength that I think will persist for Q3 and Q4 of 2021, taking the stock to way higher prices.
The immediate target is the 15 cents level, and then the 20 cents level, watch these. If these higher levels are taken, the stock could see a fast rise to levels unseen since 2018-2019.
면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.